Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomePreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Acquisitions (2021 - 2024)

DarioHealth filings provide 3 years of Acquisitions readings, the most recent being $8.8 million for Q1 2024.

  • On a quarterly basis, Acquisitions changed N/A to $8.8 million in Q1 2024 year-over-year; TTM through Dec 2024 was $8.8 million, a N/A change, with the full-year FY2024 number at $8.8 million, changed N/A from a year prior.
  • Acquisitions hit $8.8 million in Q1 2024 for DarioHealth, up from $115000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $8.8 million in Q1 2024 to a low of -$26000.0 in Q4 2021.
  • Median Acquisitions over the past 3 years was $2.5 million (2021), compared with a mean of $2.8 million.
  • The widest YoY moves for Acquisitions: up 95.35% in 2022, down 95.35% in 2022.
  • DarioHealth's Acquisitions stood at -$26000.0 in 2021, then soared by 542.31% to $115000.0 in 2022, then skyrocketed by 7548.7% to $8.8 million in 2024.
  • The last three reported values for Acquisitions were $8.8 million (Q1 2024), $115000.0 (Q1 2022), and -$26000.0 (Q4 2021) per Business Quant data.